NOVELIX PHARMACEUTICALS INC has a total of 15 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are UNION INTERNATIONAL CO LTD, UMECRINE COGNITION AB and ENDORECH INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | China | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Steroids | |
#4 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Jansen Burkhard | 11 |
#2 | Selzer Edgar | 5 |
#3 | Paschke Reinhard | 5 |
#4 | O'Neill Mike H | 3 |
#5 | Bauer Victor J | 3 |
#6 | Kidon Barbara J | 3 |
#7 | Jansen M D Burkhard | 2 |
#8 | Burkhard Jansen | 1 |
#9 | Jansen Burkhard M D | 1 |
#10 | Reinhard Paschke | 1 |
Publication | Filing date | Title |
---|---|---|
EP2371368A2 | Compositions and methods for treatment of inflammation and hyperkeratotic lesions | |
WO2009126743A1 | Novel (pyrroloquinoxalinyl) pyrazinecarbohydrazide-oxalic acid co-crystal for treatment of cancer and other diseases | |
US2006252733A1 | Betulin, betulin derivatives, betulinic acid and betulinic acid derivatives as novel therapeutics in the treatment of disease of lipid and/or glucose metabolism | |
CA2515384A1 | Medicament for inhibiting tumour growth |